- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Price increase of geriatric drugs in the U.S. in 2017, by manufacturer
Price increase of geriatric drugs in the U.S. in 2017, by manufacturer
Average price increase of brand name drugs widely used by older adults in the U.S. as of 2017, by manufacturer*
by Matej Mikulic,
last edited
Sep 27, 2019
This statistic depicts the average price increase of brand name drugs widely used by older adults in the U.S. during 2017, by manufacturer. According to the source, Astellas had four drugs that increased in price by an average of 17 percent during 2017.
Average price increase of brand name drugs widely used by older adults in the U.S. as of 2017, by manufacturer*
Loading statistic...
Expand statistic
| Manufacturer (number of drugs) | Price increase |
|---|---|
| PCCA (3) | 269.2% |
| Astellas (4) | 17% |
| Sankyo (11) | 14.3% |
| Pfizer U.S. (24) | 13.8% |
| Lundbeck (2) | 11.4% |
| Aptalis Pharma (2) | 9.3% |
| Cephalon (2) | 9.2% |
| Shire US Inc. (2) | 9.1% |
| Purdue Pharma L.P. (6) | 8.8% |
| Merck/Schering-Plough Pharm (4) | 8.5% |
| Actavis (17) | 8.4% |
| Allergan (4) | 8.1% |
| Horizon Pharma (2) | 8% |
| Janssen (10) | 7.4% |
| Merck Sharp and Dohme (13) | 7.4% |
| Alcon Vision (8) | 7.3% |
| Amgen (3) | 7% |
| Novartis (16) | 6.9% |
| UCB Pharma (2) | 6.8% |
| Genentech (5) | 6.6% |
| Boehringer Ingelheim (8) | 6.5% |
| Valent (12) | 6.1% |
| Gilead Sciences (2) | 5.9% |
| Lilly (10) | 5.8% |
| AbbVie (13) | 5.4% |
| All others (13) | 5.2% |
| Glaxo Smith Kline (13) | 5.2% |
| Teva (3) | 4.7% |
| Endo Pharmaceuticals (2) | 4.4% |
| Takeda Pharmaceuticals (5) | 4% |
| Novo Nordisk (8) | 3.8% |
| Sanofi-Aventis U.S. (4) | 2.8% |
| Sunovion Pharmaceucticals (4) | 2.6% |
| AstraZeneca (19) | 2.6% |
| Bristo-Myers Squibb (9) | 0.8% |
| Genzyme (2) | -1.9% |
| Manufacturer (number of drugs) | Price increase |
|---|---|
| PCCA (3) | 269.2% |
| Astellas (4) | 17% |
| Sankyo (11) | 14.3% |
| Pfizer U.S. (24) | 13.8% |
| Lundbeck (2) | 11.4% |
| Aptalis Pharma (2) | 9.3% |
| Cephalon (2) | 9.2% |
| Shire US Inc. (2) | 9.1% |
| Purdue Pharma L.P. (6) | 8.8% |
| Merck/Schering-Plough Pharm (4) | 8.5% |
| Actavis (17) | 8.4% |
| Allergan (4) | 8.1% |
| Horizon Pharma (2) | 8% |
| Janssen (10) | 7.4% |
| Merck Sharp and Dohme (13) | 7.4% |
| Alcon Vision (8) | 7.3% |
| Amgen (3) | 7% |
| Novartis (16) | 6.9% |
| UCB Pharma (2) | 6.8% |
| Genentech (5) | 6.6% |
| Boehringer Ingelheim (8) | 6.5% |
| Valent (12) | 6.1% |
| Gilead Sciences (2) | 5.9% |
| Lilly (10) | 5.8% |
| AbbVie (13) | 5.4% |
| All others (13) | 5.2% |
| Glaxo Smith Kline (13) | 5.2% |
| Teva (3) | 4.7% |
| Endo Pharmaceuticals (2) | 4.4% |
| Takeda Pharmaceuticals (5) | 4% |
| Novo Nordisk (8) | 3.8% |
| Sanofi-Aventis U.S. (4) | 2.8% |
| Sunovion Pharmaceucticals (4) | 2.6% |
| AstraZeneca (19) | 2.6% |
| Bristo-Myers Squibb (9) | 0.8% |
| Genzyme (2) | -1.9% |
© Statista 2019
About this statistic
Sources: AARP; University of Minnesota; Truven Health Analytics
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Sep 27, 2019
This statistic depicts the average price increase of brand name drugs widely used by older adults in the U.S. during 2017, by manufacturer. According to the source, Astellas had four drugs that increased in price by an average of 17 percent during 2017.
- Sources
- AARP; University of Minnesota; Truven Health Analytics
- Show further sources information
- Show publisher information
- Release date
- September 2018
- Region
- United States
- Survey time period
- 2017
- Supplementary notes
- * Based on top 267 drug products most widely used by older Americans.
Source
- Sources
- AARP; University of Minnesota; Truven Health Analytics
- Show further sources information
- Show publisher information
- Release date
- September 2018
More information
- Region
- United States
- Survey time period
- 2017
- Supplementary notes
- * Based on top 267 drug products most widely used by older Americans.
Other statistics on the topic
+Pharmaceutical Products & Market
Research and development in European pharmaceutical industry by country 2017
+Pharmaceutical Products & Market
VAT rate on prescription-only drugs in Europe 2018
Pharmaceutical Products & Market
Market share of generics in European countries 2017
+Pharmaceutical Products & Market
Yearly growth rate of R&D spending in pharmaceutical industry 2004-2018
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.Marlene Greenfield
Vice President, Hearst Magazines
Statistics on "Pharmaceutical trends in Europe"
- Overview
The most important statistics
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)Turnover of leading European pharmaceutical markets 2017
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)Turnover of pharmaceutical markets in Central and Eastern Europe 2017
- Share of breakdown of pharmaceutical price structure in Europe in 2016*Pharmaceutical price structure breakdown in Europe 2016
- Value Added Tax (VAT) rate on over-the-counter (OTC) drugs in Europe in 2018, by country*VAT rate on over-the-counter drugs in Europe 2018, by country
- Value Added Tax (VAT) rate on prescription-only drugs in Europe in 2018, by countryVAT rate on prescription-only drugs in Europe 2018
- Share of GDP expenditure on research and development in the EU-28 countries from 2000 to 2017*European Union: share of GDP expenditure on research and development 2000-2017
- Pharmaceutical research and development spending in selected European countries in 2017 (in million euros)Research and development in European pharmaceutical industry by country 2017
- Annual growth of pharmaceutical R&D spending in Europe and the U.S. between 2004 and 2018Yearly growth rate of R&D spending in pharmaceutical industry 2004-2018
- European Pharmaceutical companies
The most important statistics
- Leading 18 European pharmaceutical companies by retail sales in 2018 (in billion U.S. dollars)Leading 18 European pharmaceutical companies by retail sales 2018
- Leading European pharmaceutical companies by spending on research and development in 2018 (in billion U.S. dollars)Leading European pharmaceutical companies by R&D spending 2018
- Pharmaceutical production value of EFPIA members from 1990 to 2018 (in million euros)Members of EFPIA's pharmaceutical production value 1990-2018
- Pharmaceutical research and development spending of EFPIA members from 1990 to 2018 (in million euros)Members of EFPIA's pharmaceutical R&D spending 1990-2018
- Self-medication market
The most important statistics
- Sales in the self-medication market in selected European countries in 2017 (in million euro)Self-medication market sales in Europe in 2017, by country
- Sales of analgesics in the self-medication market in Europe in 2017, by country (in million euro)Self-medication market sales of analgesics in Europe in 2017, by country
- Sales of cough and cold products in the self-medication market in Europe in 2017, by country (in million euro)Cough and cold self-medication market sales in Europe in 2017
- Sales of digestives and intestinal remedies in the self-medication product market in Europe in 2017, by country (in million euro)Digestives and intestinal remedies self-medication market sales in Europe 2017
- Sales of self-medication skin treatment products in Europe in 2017, by country (in million euros)Self-medication skin treatment product sales in Europe 2017, by country
- Sales of vitamin and mineral products in the self medication market in Europe in 2017, by country (in million euro)Self-medication: sales of vitamins and minerals in Europe 2017
- Market value of self-medication drugs in Italy from 2014 to 2017 (in million euros)Italy: market value of self-medication drugs 2014-2017
- Sales revenue of self-care medicines in the Netherlands in 2017, by purchase channel (in million euros)Sales revenue of self-care medicines in the Netherlands 2017, by purchase channel
- Employment
The most important statistics
- Pharmaceutical employment in selected European countries in 2017Employment in European pharmaceutical industry by country 2017
- Total pharmaceutical employment in EFPIA countries from 1990 to 2018Employment in EFPIA pharmaceutical industry 1990-2018
- Employment in pharmaceutical products and preparations manufacturing in the United Kingdom from 2008 to 2017 (in 1,000s)Pharmaceutical manufacturing employment in the United Kingdom 2008-2017
- Number of employees in biotechnology companies, split by private or public sector in Switzerland from 2012 to 2017Switzerland: number of employees in biotech companies 2012-2017
- Number of employees in the pharmaceutical industry in Germany from 2010 to 2016Pharmaceutical industry: number of employees in Germany 2010-2016
- Number of employees in the pharmaceutical industry in Belgium from 2014 to 2017Number of employees in the pharmaceutical industry in Belgium 2014-2017
- Number of employees of pharmaceutical companies in France in 2014, by region of residenceNumber of employees of pharmaceutical companies by region France 2014
- Number of employees in the pharmaceutical industry in Italy between 2000 and 2018Number of employees in the pharmaceutical industry in Italy 2000-2018
- Clinical Trials
The most important statistics
- Distribution of European clinical and phase III pipeline in 2013, by indicationDistribution of European clinical and phase III pipeline 2013 by indication
- Number of clinical trials submitted to the European Medicines Agency from European countries from 2005 to 2011Pivotal trials submitted to the European Medicines Agency from Europe 2005-2011
- Number of patients per clinical trial in selected European countries from 2005 to 2011Patients in clinical trials in selected European countries 2005-2011
- Number of applications to conduct a clinical trial submitted to BfArM and PEI* in Germany from 2009 to 2017Clinical trial conduct applications in Germany 2009-2017
- Number of clinical trials authorized by the competent authority in Italy from 2003 to 2017Italy: number of clinical trials authorized in Italy 2003-2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Price increase of brand drugs mostly used by US seniors by use and competition 2017
- Price increase top 5 geriatric drugs in the U.S. in 2017
- Number of geriatric drugs that had retail price increase in the U.S. 2017
- Annual price change in name brand drugs used mostly by older adults 2006-2017
- Annual prices for geriatric drugs with limits for inflation 2006-2017
- Select pharmaceutical price increases in the U.S. 2013-2014
- Price growth of selected pharmaceutical products in the U.S. 2013 and 2014
- Drug price changes in the U.S. by product group until end-2019
- Average Parkinson's neuromodulation device price U.S. 2018, by manufacturer
- Annual cost of MS drugs in the United States from approval date to 2013
- Annual cost of MS drugs by select countries 2013-2014
- Number of oral drug shortages in Canada 2013-2016, by pharmaceutical company
- Price disparities for Spiriva Handihaler - U.S. and international 2017
- Distribution of oral drug shortages in pharmaceutical companies in Canada 2013-2016
- Price disparities for top product Januvia - U.S. and international 2017
- Price disparities for top product Xarelto - U.S. and international 2017
- Price disparities for top product Viagra - U.S. and international 2017
- Price disparities for top product Tamiflu - U.S. and international 2017
- Price disparities for top product Nasonex - U.S. and international 2017
- Price disparities for top product Symbicort - U.S. and international 2017
Studies
- The Controversey over Rising Drug Prices: The Public's View
- Pharmaceutical industry in India
- Boehringer Ingelheim - Annual Report 2018
- Global Participation in Clinical Trials Report 2015-2016
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans, 2006 to 2013
- La Industria Farmaceutica Latinoamericana 2011
Statistics on "Pharmaceutical trends in Europe"
- Turnover of leading European pharmaceutical markets 2017
- Turnover of pharmaceutical markets in Central and Eastern Europe 2017
- Pharmaceutical price structure breakdown in Europe 2016
- VAT rate on over-the-counter drugs in Europe 2018, by country
- VAT rate on prescription-only drugs in Europe 2018
- European Union: share of GDP expenditure on research and development 2000-2017
- Research and development in European pharmaceutical industry by country 2017
- Yearly growth rate of R&D spending in pharmaceutical industry 2004-2018
- Market share of generics in European countries 2017
- Leading 18 European pharmaceutical companies by retail sales 2018
- Leading European pharmaceutical companies by R&D spending 2018
- Members of EFPIA's pharmaceutical production value 1990-2018
- Members of EFPIA's pharmaceutical R&D spending 1990-2018
- Self-medication market sales in Europe in 2017, by country
- Self-medication market sales of analgesics in Europe in 2017, by country
- Cough and cold self-medication market sales in Europe in 2017
- Digestives and intestinal remedies self-medication market sales in Europe 2017
- Self-medication skin treatment product sales in Europe 2017, by country
- Self-medication: sales of vitamins and minerals in Europe 2017
- Italy: market value of self-medication drugs 2014-2017
- Sales revenue of self-care medicines in the Netherlands 2017, by purchase channel
- Revenue of self-care medicines in supermarkets in the Netherlands 2017, by segment
- Employment in European pharmaceutical industry by country 2017
- Employment in EFPIA pharmaceutical industry 1990-2018
- Pharmaceutical manufacturing employment in the United Kingdom 2008-2017
- Switzerland: number of employees in biotech companies 2012-2017
- Pharmaceutical industry: number of employees in Germany 2010-2016
- Number of employees in the pharmaceutical industry in Belgium 2014-2017
- Number of employees of pharmaceutical companies by region France 2014
- Number of employees in the pharmaceutical industry in Italy 2000-2018
- Distribution of European clinical and phase III pipeline 2013 by indication
- Pivotal trials submitted to the European Medicines Agency from Europe 2005-2011
- Patients in clinical trials in selected European countries 2005-2011
- Clinical trial conduct applications in Germany 2009-2017
- Italy: number of clinical trials authorized in Italy 2003-2017
- Price increase of brand drugs mostly used by US seniors by use and competition 2017
- Price increase top 5 geriatric drugs in the U.S. in 2017
- Number of geriatric drugs that had retail price increase in the U.S. 2017
- Annual price change in name brand drugs used mostly by older adults 2006-2017
- Annual prices for geriatric drugs with limits for inflation 2006-2017
- Select pharmaceutical price increases in the U.S. 2013-2014
- Price growth of selected pharmaceutical products in the U.S. 2013 and 2014
- Drug price changes in the U.S. by product group until end-2019
- Average Parkinson's neuromodulation device price U.S. 2018, by manufacturer
- Annual cost of MS drugs in the United States from approval date to 2013
- Annual cost of MS drugs by select countries 2013-2014
- Number of oral drug shortages in Canada 2013-2016, by pharmaceutical company
- Price disparities for Spiriva Handihaler - U.S. and international 2017
- Distribution of oral drug shortages in pharmaceutical companies in Canada 2013-2016
- Price disparities for top product Januvia - U.S. and international 2017
- Price disparities for top product Xarelto - U.S. and international 2017
- Price disparities for top product Viagra - U.S. and international 2017
- Price disparities for top product Tamiflu - U.S. and international 2017
- Price disparities for top product Nasonex - U.S. and international 2017
- Price disparities for top product Symbicort - U.S. and international 2017
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month*
| |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Yes, let me download!
...and make my research life easier.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.